RecruitingNot ApplicableNCT05112211

Multi-model Image of Doxycycline in TAO

A Multi-model Image to Evaluate the Efficacy of Doxycycline in Thyroid Associated Ophthalmopathy

Sponsor

Sun Yat-sen University

Enrollment

20 participants

Start Date

Jan 1, 2022

Study Type

INTERVENTIONAL

Conditions

Thyroid Associated Ophthalmopathy

Summary

This study aims to evaluate the efficacy of doxycycline treating Thyroid Associated Ophthalmopathy by multi-modal image.

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Doxycycline Hyclate for people with thyroid associated ophthalmopathy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.